About this Abstract |
Meeting |
MS&T21: Materials Science & Technology
|
Symposium
|
Next Generation Biomaterials
|
Presentation Title |
A Breath Test for COVID-19 |
Author(s) |
Pelagia Gouma |
On-Site Speaker (Planned) |
Pelagia Gouma |
Abstract Scope |
COVID-19 disease is a pandemic caused by the SARS-CoV-2 virus. The early stages of infection cannot be detected by the molecular tests used currently. This work features a new and revolutionary approach to diagnose COVID-19 infection from sampling a single human (breath) exhale for gaseous signaling metabolites of the disease, that is COVID-19 biomarkers. The relative change in the concentration of these biomarkers upon the subject’s infection with the SARS-CoV-2 virus provides an early and distinct signal of this infection. Measurements were made repeatedly on infected subjects to map the severity of the disease and to identify when the subject had recovered. Thus, a novel screening/diagnostic tool for the pandemic infection has been developed. |